Finance

Lists
Why is 300363 up 7.35%?
Dive Deeper
300363:SHE
Porton Pharma Solutions Ltd
CN¥24.09
+7.35%
(+1.65) 1D
Nov 4, 3:04:22 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 300363...
Open
CN¥22.43
High
CN¥24.23
Low
CN¥22.04
Mkt. cap
12.04B
Avg. vol.
18.30M
Volume
24.46M
Dividend
0.37%
Quarterly dividend
CN¥0.02
Ex-dividend date
May 12, 2026
52-wk high
CN¥30.40
52-wk low
CN¥13.24
EPS
-CN¥0.17
Shares outstanding
536.66M
No. of employees
4K
Open
CN¥22.43
High
CN¥24.23
Low
CN¥22.04
Mkt. cap
12.04B
Avg. vol.
18.30M
Volume
24.46M
Dividend
0.37%
Quarterly dividend
CN¥0.02
Ex-dividend date
May 12, 2026
52-wk high
CN¥30.40
52-wk low
CN¥13.24
EPS
-CN¥0.17
Shares outstanding
536.66M
No. of employees
4K
News stories
From web sources and news partners
About Porton Pharma Solutions Ltd
CEO-
Employees4.4K
FoundedJul 7, 2005
Headquarters-
SectorPharmaceutical industry
Industry-
Websiteporton.cn
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
875.40M
886.04M
903.85M
974.81M
Cost of goods sold
614.29M
614.92M
607.13M
615.42M
Cost of revenue
614.29M
614.92M
607.13M
615.42M
Research and development expenses
53.23M
45.16M
60.98M
75.31M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
167.98M
161.88M
154.77M
139.36M
Operating expense
236.13M
227.23M
224.22M
200.17M
Total operating expenses
850.42M
842.15M
831.35M
815.59M
Operating income
24.98M
43.89M
72.50M
159.22M
Other non operating income
14.47M
-8.83M
5.66M
-46.47M
EBT including unusual items
20.51M
21.68M
-244.93M
121.83M
EBT excluding unusual items
8.03M
27.51M
73.78M
133.10M
Income tax expense
14.60M
15.37M
16.44M
23.91M
Effective tax rate
71.17%
70.90%
-6.71%
19.63%
Other operating expenses
14.33M
12.69M
10.72M
-9.26M
Net income
16.42M
27.87M
-252.07M
112.05M
Net profit margin
1.88%
3.14%
-27.89%
11.49%
Earnings per share
-
-
-
-
Interest and investment income
985.41K
3.18M
11.91M
21.19M
Interest expense
-8.10M
-10.74M
-10.45M
-6.67M
Net interest expenses
-7.12M
-7.55M
1.46M
14.51M
Depreciation and amortization charges
-
-
-
-
EBITDA
113.03M
131.93M
158.08M
247.26M
Gain or loss from assets sale
1.17M
-
2.63M
-2.63M
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps